Post-COVID-19 Condition: Clinical Trials

8 trials for Post-COVID-19 Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 2 recruiting, 1 available, 1 completed. 2 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Enrolling by invitation 1, Recruiting 1
Phase 21Completed 1
Phase 31Not yet recruiting 1
Phase 41Not yet recruiting 1

Follow Post-COVID-19 Condition: new trials by email Literature Review of Post-COVID-19 Condition trials Research Report on Post-COVID-19 Condition

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
The Precision Mito- Mito Map COMPASS Study
Mito Map Energy Score and Home Functional Assessments - Mitochondrial Diseases, Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Not yet recruitingAI Agent Vault, Inc. d/b/a Precision Mito4002026-11-012026-10-02
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
REGENECYTE, Placebo - Long COVID, Post-COVID-19 Condition
Phase 3Not yet recruitingStemCyte, Inc.602026-03-312025-09-23
Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients
Long COVID, Post-COVID-19 Condition
RecruitingUniversitair Ziekenhuis Brussel542026-01-212026-04-22
Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition
Hyperbaric Oxygen therapy - Long COVID, Post Acute Sequelae of COVID-19
Not applicableRecruitingUniversity Health Network, Toronto1202026-01-012026-02-23
Vortioxetine for Post-COVID-19 Condition
Vortioxetine, Placebo - Post-COVID-19 Condition, Post-COVID-19 Syndrome
Phase 2CompletedBrain and Cognition Discovery Foundation1492021-09-162025-01-16
Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments
eRehabCog, CogMed QM - Traumatic Brain Injury, Stroke
Not applicableEnrolling by invitationAniko Bartfai642021-05-022025-05-15
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
REGENECYTE® - Post-COVID-19 Condition, Post-COVID Condition
AvailableStemCyte, Inc.2026-03-23

Narrower conditions

Post-Acute COVID-19 Syndrome (5)  ·  Fatigue (2)  ·  Mitochondrial Diseases (2)  ·  Multiple Sclerosis (2)  ·  Brain Injuries (1)  ·  Brain Injuries, Traumatic (1)  ·  Calciphylaxis (1)  ·  Cognition Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Colitis, Ulcerative (1)  ·  Craniocerebral Trauma (1)  ·  Crohn Disease (1)  ·  Enterocolitis, Pseudomembranous (1)  ·  Epidermolysis Bullosa (1)  ·  Fibromyalgia (1)

Broader conditions

Infections (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Chronic Disease (6)  ·  Disease Attributes (6)  ·  Post-Infectious Disorders (6)  ·  COVID-19 (5)  ·  Coronaviridae Infections (5)  ·  Coronavirus Infections (5)  ·  Lung Diseases (5)  ·  Nidovirales Infections (5)  ·  Pneumonia (5)  ·  Pneumonia, Viral (5)  ·  RNA Virus Infections (5)  ·  Respiratory Tract Diseases (5)

Interventions

Hyperbaric Oxygenation (1)  ·  Oxygen (1)  ·  Vortioxetine (1)

Sponsors

StemCyte, Inc. (2)  ·  AI Agent Vault, Inc. d/b/a Precision Mito (1)  ·  Aniko Bartfai (1)  ·  Brain and Cognition Discovery Foundation (1)  ·  Jay C. Buckey Jr. (1)  ·  Universitair Ziekenhuis Brussel (1)  ·  University Health Network, Toronto (1)

Countries

Canada (2)  ·  United States (2)  ·  Belgium (1)  ·  Sweden (1)

Top investigators

Andrew Friedl, MS, MBA (1)  ·  Angela M Cheung, MD, PhD (1)  ·  Aniko Bartfai, PhD (1)  ·  Deborah Manst, MD (1)  ·  Elisabeth De Waele, MD. PhD. (1)  ·  Jay Buckey (1)  ·  Rita Katznelson, MD (1)  ·  Roger S. McIntyre, MD, FRCPC (1)

Results publications

PMID 38114867, PMID 38424537, PMID 38520501, PMID 38860901, PMID 38954402